Nanoparticle-Mediated Toll-Like Receptor Activation and Dual Immune Checkpoint Downregulation for Potent Cancer Immunotherapy
2025 · ACS Nano · 7 citations
https://doi.org/10.1021/acsnano.4c16542
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
25
Citations
2
h-index
1
i10-index
Richard Zanni is an academic researcher from University of Chicago. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Immunotherapy and Immune Responses & Luminescence and Fluorescent Materials. The author has an h-index of 2, co-authored 2 publications.
Click to start Chat